Prior Endocrine Therapy Impact on Abiraterone Acetate Clinical Efficacy in Metastatic Castration-resistant Prostate Cancer: Post-hoc Analysis of Randomised Phase 3 Studies Academic Article uri icon

Overview

MeSH Major

  • Androgens
  • Gene Expression Regulation, Enzymologic
  • Gene Expression Regulation, Neoplastic
  • Prostatic Neoplasms

abstract

  • Metastatic castration-resistant prostate cancer patients derived clinical benefits with abiraterone acetate regardless of prior endocrine therapy duration.

publication date

  • May 2016

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC5465643

Digital Object Identifier (DOI)

  • 10.1016/j.eururo.2015.10.021

PubMed ID

  • 26508309

Additional Document Info

volume

  • 69

number

  • 5